{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:50:19Z","timestamp":1791895819555,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1U01MH124639\\u201301"],"award-info":[{"award-number":["1U01MH124639\\u201301"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["5P50MH115846\\u201303"],"award-info":[{"award-number":["5P50MH115846\\u201303"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R01MH128971-01A1"],"award-info":[{"award-number":["1R01MH128971-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101057182"],"award-info":[{"award-number":["101057182"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101156514"],"award-info":[{"award-number":["101156514"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM23\/00091"],"award-info":[{"award-number":["CM23\/00091"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01824"],"award-info":[{"award-number":["PI22\/01824"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI25\/01218"],"award-info":[{"award-number":["PI25\/01218"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR19\/00024"],"award-info":[{"award-number":["JR19\/00024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00721"],"award-info":[{"award-number":["PI20\/00721"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00625"],"award-info":[{"award-number":["PI23\/00625"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PMP21\/00051"],"award-info":[{"award-number":["PMP21\/00051"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115916"],"award-info":[{"award-number":["115916"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.08.036","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:08:34Z","timestamp":1788444514000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study"],"prefix":"10.1016","volume":"297","author":[{"given":"Joaqu\u00edn","family":"Galva\u00f1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier-David","family":"Lopez-Morinigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Salazar de Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Luis","family":"Ayuso-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic","family":"Van der Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W.J.H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martien J.H.","family":"Kas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Covadonga M.","family":"D\u00edaz-Caneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.08.036_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2018.06.019","article-title":"Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer\u2019s disease","volume":"97","author":"Bilderbeck","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.08.036_bb0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1192\/bjp.157.6.853","article-title":"The social functioning scale the development and validation of a new scale of social adjustment for use in family intervention Programmes with schizophrenic patients","volume":"157","author":"Birchwood","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0015","series-title":"Dementia Praecox or the Group of Schizophrenias","author":"Bleuler","year":"1950"},{"key":"10.1016\/j.schres.2026.08.036_bb0020","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbi028","article-title":"Significance and meaning of neurological signs in schizophrenia: two decades later","volume":"31","author":"Bombin","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the extrapyramidal symptom rating scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2017.08.050","article-title":"Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning","volume":"200","author":"Cuesta","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.10.035","article-title":"Motor abnormalities and cognitive impairment in first-episode psychosis patients, their unaffected siblings and healthy controls","volume":"200","author":"Cuesta","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0040","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1017\/S0033291720000343","article-title":"Motor abnormalities and basal ganglia in first-episode psychosis (FEP)","volume":"51","author":"Cuesta","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.08.036_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2025.10455","article-title":"Epilepsy and mental health disorders: current challenges and potential solutions","author":"De Giorgi","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10433-010-0144-6","article-title":"The De Jong Gierveld short scales for emotional and social loneliness: tested on data from 7 countries in the UN generations and gender surveys","volume":"7","author":"De Jong Gierveld","year":"2010","journal-title":"Eur. J. Ageing"},{"key":"10.1016\/j.schres.2026.08.036_bb0055","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00406-021-01354-9","article-title":"Characterizing the sensorimotor domain in schizophrenia spectrum disorders","volume":"272","author":"Fritze","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.08.036_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/schbul\/sbae055","article-title":"Parkinsonism, psychomotor slowing, negative and depressive symptoms in schizophrenia Spectrum and mood disorders: exploring their intricate Nexus using a network analytic approach","volume":"51","author":"Fritze","year":"2025","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2025.06.007","article-title":"Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial","volume":"98","author":"Galva\u00f1","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.08.036_bb0070","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0269881105051539","article-title":"Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness","volume":"19","author":"Honer","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.08.036_bb0080","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s11434-011-4738-y","article-title":"First episode psychosis with extrapyramidal signs prior to antipsychotic drug treatment","volume":"56","author":"Honer","year":"2011","journal-title":"Chin. Sci. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","article-title":"Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients","volume":"161","author":"Janno","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-301184","article-title":"Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis","volume":"27","author":"Kalniunas","year":"2024","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.schres.2026.08.036_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neubiorev.2017.12.008","article-title":"A quantitative approach to neuropsychiatry: the why and the how","volume":"97","author":"Kas","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.08.036_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.psychres.2011.01.005","article-title":"Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis","volume":"188","author":"Koning","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0115","series-title":"Dementia Praecox and Paraphrenia","author":"Kraepelin","year":"1919"},{"key":"10.1016\/j.schres.2026.08.036_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2026.08.036_bb0125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2026.08.036_bb0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0135","first-page":"64","article-title":"Extrapyramidal symptoms predict cognitive performance after first-episode psychosis","volume":"8","author":"Lindgren","year":"2022","journal-title":"Schizophrenia (Heidelberg, Germany)"},{"key":"10.1016\/j.schres.2026.08.036_bb0140","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/mds.29392","article-title":"Scales for antipsychotic-associated movement disorders: systematic review, critique, and recommendations","volume":"38","author":"Martino","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2026.08.036_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20693","article-title":"Dopamine and glutamate in schizophrenia: biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/2.1.19","article-title":"The dopamine hypothesis of schizophrenia: a review","volume":"2","author":"Meltzer","year":"1976","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0155","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12246","article-title":"Prevalence of and risk factors for extrapyramidal side effects of antipsychotics: results from the national FACE-SZ cohort","volume":"80","author":"Misdrahi","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0920-9964(99)00133-4","article-title":"Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia","volume":"42","author":"Modestin","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2007.10.018","article-title":"Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment","volume":"100","author":"Modestin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.schres.2022.08.015","article-title":"Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: a 4-year follow-up naturalistic study","volume":"248","author":"Monteleone","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152307","article-title":"Motor abnormalities are associated with poor social and functional outcomes in schizophrenia","volume":"115","author":"Nadesalingam","year":"2022","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0180","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0033291708004716","article-title":"Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review","volume":"39","author":"Pappa","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.08.036_bb0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.comppsych.2010.05.009","article-title":"Neuromotor abnormalities in neuroleptic-naive psychotic patients: antecedents, clinical correlates, and prediction of treatment response","volume":"52","author":"Peralta","year":"2011","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0190","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/schbul\/sbx089","article-title":"Motor abnormalities: From neurodevelopmental to neurodegenerative through \u201cfunctional\u201d (neuro)psychiatric disorders","volume":"43","author":"Peralta","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/JCP.0b013e31828f62b0","article-title":"Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-Spectrum disorders","volume":"33","author":"Peralta","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.08.036_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.schres.2017.08.039","article-title":"Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment","volume":"200","author":"Peralta","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2020-000057","article-title":"Movement disorders in psychiatric patients","volume":"2","author":"Perju-Dumbrava","year":"2020","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.schres.2026.08.036_bb0210","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/schbul\/sbab028","article-title":"Exploring the relationship between movement disorders and physical activity in patients with schizophrenia: an Actigraphy study","volume":"47","author":"Pieters","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0215","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neubiorev.2021.11.027","article-title":"A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis","volume":"132","author":"Pieters","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.08.036_bb0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0447.1926.tb11031.x","article-title":"Extrapyramidal motor-Disturrances in dementia praecox","volume":"1","author":"Reiter","year":"1926","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.08.036_bb0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and Meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0230","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.euroneuro.2014.07.001","article-title":"Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST","volume":"24","author":"Rybakowski","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 20","key":"10.1016\/j.schres.2026.08.036_bb0235","first-page":"22","article-title":"The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0240","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","article-title":"Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis","volume":"28","author":"Siafis","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2026.08.036_bb0250","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2012.06.003","article-title":"[123I]FP-CIT single photon emission computed tomography findings in drug-induced parkinsonism","volume":"139","author":"Tinazzi","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.036_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S0033291700011004","article-title":"Rich and mad in Victorian England","volume":"19","author":"Turner","year":"1989","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.08.036_bb0260","author":"UK Goverment"},{"key":"10.1016\/j.schres.2026.08.036_bb0265","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41380-020-0660-5","article-title":"The genetics of drug-related movement disorders, an umbrella review of meta-analyses","volume":"25","author":"Van Der Burg","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neubiorev.2018.06.020","article-title":"Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer\u2019s disease","volume":"97","author":"Van Der Wee","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.08.036_bb0275","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neubiorev.2017.06.007","article-title":"The clinical and prognostic value of motor abnormalities in psychosis, and the importance of instrumental assessment","volume":"80","author":"Van Harten","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.08.036_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11920-017-0856-9","article-title":"Motor system pathology in psychosis","volume":"19","author":"Walther","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.schres.2026.08.036_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2020.07.003","article-title":"Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives","volume":"38","author":"Walther","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.08.036_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2018-100026","article-title":"Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia","volume":"32","author":"Weng","year":"2019","journal-title":"Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.08.036_bb0295","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbn126","article-title":"Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology","volume":"35","author":"Whitty","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.036_bb0300","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/schbul\/sbaa007","article-title":"A neural signature of parkinsonism in patients with schizophrenia Spectrum disorders: a multimodal MRI study using parallel ICA","volume":"46","author":"Wolf","year":"2020","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:10:09Z","timestamp":1791893409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":60,"alternative-id":["S0920996426002872"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.036","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}